Ignite Creation Date:
2024-05-06 @ 9:43 AM
Last Modification Date:
2024-10-26 @ 12:18 PM
Study NCT ID:
NCT03054363
Status:
COMPLETED
Last Update Posted:
2023-11-13
First Post:
2017-02-07
Brief Title:
Tucatinib Palbociclib and Letrozole in Metastatic Hormone Receptor Positive and HER2-positive Breast Cancer
Sponsor:
University of Colorado Denver
Organization:
University of Colorado Denver
Organization Data
Organization:
University of Colorado Denver
Class:
OTHER
Study ID:
16-1661cc
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Colorado Denver
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Pfizer | INDUSTRY |
| Cascadian Therapeutics Inc | INDUSTRY |
| Criterium Inc | INDUSTRY |